Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Satomi Watanabe's publication output changed over time?
ScholarIQpublication output · 1989–2024
Output grew0% over the shown period — from 1 works in 1989 to 1 in 2024.
1
1
2
1
1
2
1
1
1
198920032015201620172018201920202024
What are the most-cited papers on Satomi Watanabe?
ScholarIQmost cited works
An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC
Kimio Yonesaka, Naoki Takegawa, Satomi Watanabe, Koji Haratani, Hisato Kawakami, Kazuko Sakai, Yasutaka Chiba, Naoyuki Maeda, Takashi Kagari, Kenji Hirotani, Kazuto Nishio, Kazuhiko Nakagawa
S128439998. 2018102 Citations
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors
Masayuki Takeda, Takayuki Takahama, Kazuko Sakai, Shigeki Shimizu, Satomi Watanabe, Hisato Kawakami, Kaoru Tanaka, Chihiro Sato, Hidetoshi Hayashi, Yoshikane Nonagase, Kimio Yonesaka, Naoki Takegawa, Tatsuya Okuno, Takeshi Yoshida, Soichi Fumita, Shinichiro Suzuki, Koji Haratani, Kazumasa Saigoh, Akihiko Ito, Tetsuya Mitsudomi, Hisashi Handa, Kazuya Fukuoka, Kazuhiko Nakagawa, Kazuto Nishio
The Oncologist. 202097 CitationsOPEN ACCESS
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Satomi Watanabe, Kimio Yonesaka, Junko Tanizaki, Yoshikane Nonagase, Naoki Takegawa, Koji Haratani, Hisato Kawakami, Hidetoshi Hayashi, Masayuki Takeda, Junji Tsurutani, Kazuhiko Nakagawa
Cancer Medicine. 201975 CitationsOPEN ACCESS
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
Naoki Takegawa, Kimio Yonesaka, Kazuko Sakai, Hiroto Ueda, Satomi Watanabe, Yoshikane Nonagase, Tatsuya Okuno, Masayuki Takeda, Osamu Maenishi, Junji Tsurutani, Taroh Satoh, Isamu Okamoto, Kazuto Nishio, Takao Tamura, Kazuhiko Nakagawa
Oncotarget. 201570 CitationsOPEN ACCESS
Anthocyanin production in suspension cultures of high-producing cells of Euphorbia millii.
Yoshikazu Yamamoto, Yasuhiro Kinoshita, Satomi Watanabe, Yasuyuki Yamada
S2764346059. 198957 CitationsOPEN ACCESS
Related on ScholarIQ
Kishiwada City Hospital
Institution
An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC
Paper
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors
Paper
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Paper
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
Paper
Anthocyanin production in suspension cultures of high-producing cells of Euphorbia millii.
Paper